CARD9 and Chronic mucocutaneous candidosis: In addition to cutaneous/subcutaneous and CNS fungal disease, many CARD9-deficient patients are also susceptible to persistent and recurrent infections of the mucosal surfaces by Candida species, collectively termed chronic mucocutaneous candidiasis (CMC).